U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Operations
  5. Office of Planning and Evaluation
  1. Office of Operations

Office of Planning and Evaluation


Mission Statement

OPE partners with FDA leaders to achieve organizational excellence by improving program performance, governance and operational efficiency

Vision Statement

Delivering world-class public service that drives meaningful improvements to public health outcomes with greater productivity and transparency.

Key Office Responsibilities:

The Office of Planning and Evaluation, in partnership with FDA senior management, leads the Agency through the full portfolio of planning and performance management activities called for by FDA and Administration leadership and Federal law. Our planning functions include program and policy evaluation studies, economic analyses, performance planning in support of budget formulation, business process planning, and coordination of risk communication policy, research, best practices, and analysis and development of public health outcome measures related to FDA's mission. The Office provides information and analyses that help FDA officials, the Department, and members of Congress make well-informed decisions related to programs, policies, budgets, and strategic planning. We also often serve as FDA liaison to Department and Administration planning activities that affect multiple FDA components. Our key responsibilities include the following:

  • Design and develop strategic plans, performance management systems, and business process improvements.
  • Analyze management performance trends, Agency cost structure, and use of program resources.
  • Oversee the medical products user fee performance commitments and performance management resources.
  • Analyze cost and benefits of agency regulations.
  • Provide assistance to Agency components in change management, program reinvention, and managing-to-cost.
  • Analyze risk communication activities and assists agency components in planning to improve risk communication effectiveness.

Contact the Office of Planning

Acting Director, Office of Planning and Evaluation: CAPT. Darian Tarver

Phone: 301-796-4850  E-mail: darian.tarver@fda.hhs.gov

Planning Staff: Timothy Kiang, Director
Phone: 301-796-4717 E-mail: timothy.kiang@fda.hhs.gov

Program Evaluation and Process Improvement Staff: Jessica Berrellez, Director
Phone: 301-796-0511 Email: Jessica.berrellez@fda.hhs.gov